RXDX Historical PE Ratio image   This RXDX PE ratio history page last updated 11/11/2022
RXDX Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/9/2022
49.67-0.90-3.60NA
Q2 2022
8/11/2022
47.10-0.86-3.44NA
Q1 2022
5/12/2022
23.57-0.82-3.28NA
Q4 2021
3/9/2022
49.22-0.77-3.08NA
Q3 2021
11/11/2021
37.00-0.70-2.80NA
Q2 2021
8/11/2021
22.35-0.49-1.96NA
Q1 2021
5/13/2021
16.80-1.67-6.68NA
Q3 2017
11/7/2017
15.70-0.51-2.04NA
Q2 2017
8/8/2017
9.80-0.56-2.24NA
Q1 2017
5/1/2017
8.45-0.96-3.84NA
Q4 2016
3/14/2017
8.40-0.67-2.68NA
Q3 2016
11/7/2016
4.85-0.56-2.24NA
Q2 2016
8/9/2016
5.78-0.70-2.80NA
Q1 2016
5/10/2016
6.58-0.79-3.16NA
Q4 2015
3/14/2016
7.52-1.32-5.28NA
Q3 2015
11/9/2015
10.55-0.49-1.96NA
Q2 2015
8/10/2015
14.28-0.51-2.04NA
Q1 2015
5/11/2015
9.23-1.15-4.60NA
Q4 2014
3/17/2015
7.92-0.55-2.20NA
Q3 2014
11/7/2014
6.65-0.55-2.20NA
Q2 2014
8/12/2014
7.60-0.28-1.12NA
Q1 2014
5/12/2014
7.15-0.28-1.12NA
RXDX PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/9/2022
49.67-0.90-3.35NA
Q2 2022
8/11/2022
47.10-0.86-2.45NA
Q1 2022
5/12/2022
23.57-0.82-2.29NA
Q4 2021
3/9/2022
49.22-0.77-1.47NA
Q3 2021
11/11/2021
37.00-0.70-1.19NA
Q2 2021
8/11/2021
22.35-0.49-2.67NA
Q1 2021
5/13/2021
16.80-1.67-3.70NA
Q3 2017
11/7/2017
15.70-0.51-2.70NA
Q2 2017
8/8/2017
9.80-0.56-2.75NA
Q1 2017
5/1/2017
8.45-0.96-2.89NA
Q4 2016
3/14/2017
8.40-0.67-2.72NA
Q3 2016
11/7/2016
4.85-0.56-3.37NA
Q2 2016
8/9/2016
5.78-0.70-3.30NA
Q1 2016
5/10/2016
6.58-0.79-3.11NA
Q4 2015
3/14/2016
7.52-1.32-3.47NA
Q3 2015
11/9/2015
10.55-0.49-2.70NA
Q2 2015
8/10/2015
14.28-0.51-2.76NA
Q1 2015
5/11/2015
9.23-1.15-2.53NA
Q4 2014
3/17/2015
7.92-0.55-1.66NA
Q3 2014
11/7/2014
6.65-0.55NANA
Q2 2014
8/12/2014
7.60-0.28NANA
Q1 2014
5/12/2014
7.15-0.28NANA
Quotes delayed 20 minutes

Email EnvelopeFree RXDX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Prometheus Biosciences (RXDX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

RXRX PE Ratio History
RXST PE Ratio History
RYTM PE Ratio History
RZLT PE Ratio History
SAGE PE Ratio History
SANA PE Ratio History
SAVA PE Ratio History
SBTX PE Ratio History
SCPH PE Ratio History
SCPS PE Ratio History
How should the RXDX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Prometheus Biosciences. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this RXDX Historical PE Ratio page.

What is the average historical PE for RXDX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The RXDX historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for RXDX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The RXDX historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the RXDX Historical PE Ratio information for Prometheus Biosciences' stock. The average RXDX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average RXDX historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this RXDX historical PE result, against the recent PE: when this page was posted on 11/10/2022, the most recent closing price for RXDX had been 49.08, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on RXDX or any other given stock, valuation analysis for RXDX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Prometheus Biosciences PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for RXDX. Thanks for visiting, and the next time you need to research RXDX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: AMNB Options Chain, MDEV Options Chain, Top Ten Hedge Funds Holding CTLT.

 

RXDX Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.